Ocular Therapeutix (OCUL)
(Real Time Quote from BATS)
$8.87 USD
+0.16 (1.84%)
Updated Sep 13, 2024 01:26 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Earnings News For OCUL
-
Ocular Therapeutix (OCUL) Reports Q2 Loss, Tops Revenue Estimates
-
Ocular Therapeutix: Q2 Earnings Snapshot
-
Ocular Therapeutix? Reports Second Quarter 2024 Results
-
Ocular Therapeutix: Q1 Earnings Snapshot
-
Ocular Therapeutix? Reports First Quarter 2024 Results
-
Ocular Therapeutix (OCUL) Reports Q4 Loss, Misses Revenue Estimates
-
Ocular Therapeutix: Q4 Earnings Snapshot
-
Ocular Therapeutix? Reports Fourth Quarter and Full Year 2023 Results
-
Ocular Therapeutix (OCUL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Ocular Therapeutix: Q3 Earnings Snapshot
-
Ocular Therapeutix (OCUL) Reports Q2 Loss, Tops Revenue Estimates
-
Ocular Therapeutix: Q2 Earnings Snapshot
-
Ocular Therapeutix (OCUL) Reports Q1 Loss, Lags Revenue Estimates
-
Ocular Therapeutix: Q1 Earnings Snapshot
-
Ocular Therapeutix (OCUL) Reports Q4 Loss, Tops Revenue Estimates
-
Ocular Therapeutix: Q4 Earnings Snapshot
-
Ocular Therapeutix (OCUL) Reports Q3 Loss, Lags Revenue Estimates (Revised)
-
Ocular Therapeutix: Q3 Earnings Snapshot
-
Ocular Therapeutix? Reports Third Quarter 2022 Financial Results and Business Update
-
Ocular Therapeutix (OCUL) Reports Q2 Loss, Lags Revenue Estimates
-
Ocular Therapeutix: Q2 Earnings Snapshot
-
Ocular Therapeutix? Reports Second Quarter 2022 Financial Results and Business Update
-
Ocular Therapeutix (OCUL) Reports Q1 Loss, Lags Revenue Estimates
-
Ocular Therapeutix (OCUL) Reports Q4 Loss, Lags Revenue Estimates
-
Ocular Therapeutix (OCUL) Reports Q3 Loss, Tops Revenue Estimates